2026-01-06 - Analysis Report
Okay, here's a comprehensive report on Linde PLC (LIN) based on the provided data.

**1) Return Rate Comparison (LIN vs. S&P 500)**

*   **Ticker:** LIN (Linde PLC)
*   **Company Overview:** Linde PLC is a global industrial gases and engineering company.
*   **LIN Cumulative Return:** 53.65%
*   **VOO (S&P 500) Cumulative Return:** 91.00%
*   **Divergence:**
    *   Current: -37.36% (LIN underperformed VOO by 37.36%)
    *   Relative Divergence: 13.5 (Meaning the current divergence is in the bottom 13.5% of its historical range)

*   **Analysis:** Linde has significantly underperformed the S&P 500 over the period examined. The relative divergence indicates that the underperformance is towards the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD    | Alpha   | Beta | Cap(B) |
|------------|---------|--------|---------|------|--------|
| 2016-2018  | 11.0%   | 13.9%  | 7.0%    | 0.9  | 73.8   |
| 2017-2019  | 35.0%   | 13.9%  | 18.0%   | 0.9  | 100.8  |
| 2018-2020  | 10.0%   | 16.0%  | -11.0%  | 1.0  | 124.7  |
| 2019-2021  | 58.0%   | 16.0%  | 15.0%   | 1.0  | 163.9  |
| 2020-2022  | 34.0%   | 17.4%  | 36.0%   | 1.0  | 154.4  |
| 2021-2023  | 39.0%   | 17.4%  | 38.0%   | 0.9  | 194.4  |
| 2022-2024  | 5.0%    | 17.4%  | -15.0%  | 0.8  | 198.1  |
| 2023-2025  | -12.0%  | 22.5%  | -74.0%  | 0.6  | 201.8  |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly year to year. Note the recent decline.
*   **MDD (Maximum Drawdown):**  MDD is increasing.
*   **Alpha:**  Alpha fluctuates considerably.  Recently, it has been highly negative.
*   **Beta:** Beta is generally around 0.9 to 1.0, indicating that LIN's price tends to move relatively in line with the market. Recent beta of 0.6 implies it's less volatile than the market.
*   **Cap(B) (Market Capitalization in Billions):** Market capitalization has generally trended upward, but has recently plateaued.
*   **Analysis:**  The data suggests that while Linde has experienced periods of strong growth, recent performance has been poor.  The negative alpha in recent periods suggests that LIN is underperforming relative to what would be expected given its beta.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 429.11
*   **Last Market Data:** Price = 433.1, Previous Close = 429.11, Change = 0.93
*   **5-day SMA:** 427.03
*   **20-day SMA:** 415.36
*   **60-day SMA:** 425.05

*   **Analysis:** The stock price is currently above its 5-day, 20-day, and 60-day SMAs, which could be interpreted as a short-term bullish signal. The price increase in the last market session also confirms this trend.

**3) RSI, PPO, and Divergence Analysis**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 82.71 (Overbought)
*   **PPO:** 0.4991
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** 3.5 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** 174.4% (Long-term)

*   **Analysis:** The RSI indicates that the stock is currently overbought, which could suggest a potential pullback in the short term. However, the Hybrid Signal recommends buying 90% of cash, and the MRI suggests medium investment. The recent increase in relative divergence suggests short-term upward momentum. The high Expected Return suggests that the model believes Linde will outperform the S&P 500 over the long term.

**4) Recent News & Significant Events**

*   **[2025-12-31] KWR or LIN: Which Is the Better Value Stock Right Now?** - Suggests a value comparison with another stock.
*   **[2025-12-13] Linde: Quality At Discount (NASDAQ:LIN)** - Indicates potential undervaluation.
*   **[2026-01-02] Linde (LIN) stock rises as 2026 trading kicks off; investors eye jobs data and rates** - General market sentiment impacting stock performance.
*   **[2026-01-02] Linde PLC $LIN Shares Bought by Generali Asset Management SPA SGR** - Institutional buying is generally a positive signal.
*   **[2026-01-04] UBS Turns Bullish on Linde (LIN) with New Buy Rating** - Analyst upgrades can drive price increases.
*   **[2025-12-15] One of our chipmakers has become a tech battleground stock — plus, an update on Linde** - Indicates Linde is being discussed in the context of broader market trends.

*   **Analysis:** Recent news is mostly positive, with mentions of undervaluation, institutional buying, and analyst upgrades. This could be contributing to the recent upward price movement.

**4-2) Analyst Opinions**

*   **Consensus:** Strong Buy (Mean: 1.50)
*   **Opinions:** 24
*   **Target Price:** Avg: 502.71 / High: 565.00 / Low: 381.00
*   **Recent Rating Changes:** No changes provided

*   **Analysis:** The strong buy consensus from a large number of analysts, along with a significant upside potential based on the average target price, suggests that analysts are generally optimistic about Linde's future performance.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-31 | 4.11 | 8.62 B$    |
| 2025-08-01 | 3.75 | 8.49 B$    |
| 2025-05-01 | 3.53 | 8.11 B$    |
| 2024-10-31 | 3.24 | 8.36 B$    |
| 2025-10-31 | 3.24 | 8.36 B$    |

*   **Analysis:** Both EPS and revenue have been generally increasing over the past few quarters. However, there's a duplicate entry for 2025-10-31 with different data points. Assuming the first 2025-10-31 entry is the most recent, it indicates a positive trend in earnings.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|----------------|
| 2025-09-30   | $8.62B   | 49.17%         |
| 2025-06-30   | $8.49B   | 49.31%         |
| 2025-03-31   | $8.11B   | 48.75%         |
| 2024-12-31   | $8.28B   | 47.84%         |
| 2024-09-30   | $8.36B   | 47.87%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE   |
|--------------|----------|-------|
| 2025-09-30   | $38.62B  | 5.00% |
| 2025-06-30   | $38.52B  | 4.59% |
| 2025-03-31   | $38.03B  | 4.40% |
| 2024-12-31   | $38.09B  | 4.53% |
| 2024-09-30   | $39.17B  | 3.96% |

*   **Analysis:** Revenue is generally increasing, and profit margins are consistently high and trending slightly upward. Equity is stable, and ROE has been increasing. This indicates improving profitability and efficient use of equity.

**7) Comprehensive Analysis**

*   **Summary:** Linde has underperformed the S&P 500 recently, but several indicators suggest a potential turnaround. Recent news is positive, analyst consensus is strong, earnings and financial performance are improving, and the stock is showing short-term upward momentum. However, the overbought RSI and potential near term pullback of 0.6 beta should be noted. The significant negative alpha over the past few years, and an increasing MDD, should be considered.
*   **Investment Recommendation:** The MRI of 0.8 suggests a medium investment. The hybrid signal recommends buying 90% of cash, indicating a bullish outlook.
*   **Caution:** The overbought RSI warrants caution in the short term. Further research is needed to understand the reasons for the historical underperformance and negative alpha. It's important to consider the long-term outlook and risk tolerance before making an investment decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.